1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Jiangsu Kangbeide Pharmaceutical Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2008

Location

Nanjing Jiangsu China

Primary Industry

Pharmaceuticals

About

Established in 2008 and based in Nanjing, China, Jiangsu Kangbeide Pharmaceutical Co., Ltd. operates as pharmaceutical company dedicated to providing transdermal patches and topical gel patches. It acquired 7 patents and 19 registered trademarks. In June 2015, Jiangsu Kangbeide Pharmaceutical Co., Ltd. closed series A funding from new investors Hairong Capital, Ruomu Capital, Think Investment Management, Zhejiang Aoyin Asset Management and individual investors. In August 2016, Jiangsu Kangbeide Pharmaceutical Co., Ltd. listed on the New Third Board (NEEQ). The company mainly provides transdermal patches and gel ointments The transdermal patches include 11 products, different transdermal patches are suitable for different conditions such as overactive bladder, Parkinson's disease, depression, and asthma. The gel ointments include antipyretic patch, biphenylacetic acid gel ointment, and lidocaine gel ointment. The biphenylacetic acid gel ointment is suitable for degenerative joint disease, tendon and facial low back pain, and shoulder polyarthritis. The lidocaine gel ointment is suitable for postherpetic neuralgia.
Current Investors
Hairong Capital, Think Investment Management, Ruomu Capital

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.kbdpharm.com
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2014
-
-
(6,626,802)
-
(4,954,952)
-
(6,389,536)
-
31 Dec 2015
31 Dec 2016
31 Dec 2017

Unlock the recent years of financials and more for Jiangsu Kangbeide Pharmaceutical Co., Ltd..

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.